Figure 4.
Effects of Ginkgo biloba on glycemic control markers of T2DM patients maintained treated with GKB extract and placebo, and adverse events. (A) Hemoglobin A1c (%). (B) Fasting serum glucose (mmol/L). (C) Adverse events.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.